LUT017 Gel for Venous Ulcers

This trial tests a new gel treatment called LUT017 Gel, designed to heal venous leg ulcers—painful, slow-healing wounds on the lower legs. The study aims to determine if the gel is safe and accelerates healing when applied once a week for up to eight weeks. Participants should have a chronic leg wound that hasn't healed in at least four weeks. The trial will monitor the gel's effects over six months to ensure lasting benefits and check for side effects. Interested individuals must attend regular clinic visits for treatment and follow-up. As a Phase 1 trial, this research focuses on understanding how the treatment works in people, offering participants the chance to be among the first to receive this innovative treatment.

The trial does not specify if you need to stop taking your current medications. However, if you are taking certain cancer treatments or high doses of corticosteroids, you may need to stop those before participating.

A previous study found that LUT017 gel aids the skin's natural repair process and promotes skin cell growth in animals. This suggests the gel might accelerate wound healing. However, since this trial is in an early stage, the main goal is to assess the gel's safety and how well participants tolerate it.

Participants will use one of three different strengths of the gel—0.03%, 0.1%, or 0.25%—applied once a week. Each strength will undergo safety evaluation before progressing to a stronger one. This careful approach helps identify any side effects early.

Unlike the standard of care for venous ulcers, which often involves compression therapy and wound dressings, LUT017 Gel introduces a topical approach with varying concentrations (0.03%, 0.1%, and 0.25%) applied once weekly. The gel's unique feature is its potential to enhance wound healing directly at the site, possibly due to an innovative formulation that targets skin regeneration more effectively. Researchers are excited about this treatment because it might offer a more direct and potentially faster healing process for chronic wounds, reducing the need for frequent clinic visits and improving patient comfort.

Research has shown that LUT017 gel could help heal stubborn skin wounds like venous leg ulcers. Animal studies have found that the medicine in LUT017 can kickstart the skin's natural repair process and promote cell growth, potentially speeding up wound healing. In early tests, LUT017 regenerated skin cells and improved wound healing. This trial will test different concentrations of LUT017 gel, with participants receiving either 0.03%, 0.1%, or 0.25% once weekly. Using LUT017 gel might help people with non-healing leg ulcers recover more quickly. While more research is needed in humans, these early results are promising for potential wound healing benefits.¹²³⁴⁵